Two Children With a Rare Epilepsy Mutation Show Improvement After Personalized Genetic Treatment
discovermagazine - Learn how personalized genetic therapy helped researchers treat two children with a rare form of epilepsy, enabling one to walk independently for the first time.
AI Summary: Two children with a rare, treatment‑resistant epilepsy mutation showed marked clinical improvement after receiving individualized genetic therapies—one via an antisense oligonucleotide tailored to the mutation. The cases underscore the promise of bespoke molecular medicines for devastating pediatric neurological disorders and hint that precision medicine can be both life‑changing and, yes, kind of miraculous.
Related Stories
Single‑infusion gene editing dramatically lowers LDL cholesterol in early trial / 3 months
Drug-induced hibernation shows promise to limit stroke brain injury / 2 months
Ultragenyx gene therapy becomes first FDA‑approved treatment for ultra‑rare disease / 15 days
FDA approves first drug treating full spectrum of narcolepsy symptoms / 29 days
Stem cells show potent promise as a diabetes treatment / 3 months
Mid‑stage Parkinson trial failure halts drug development plans / 3 months
Gene therapy restores hearing in about 90% of trial participants / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Wildlife, Product Recall, Biotech, Drug Development and look for the RSS link.
StackHealth Time Machine